Glenview Capital Management LLC
The positions Glenview Capital Management LLC reported on its Form 13F for Q2 2026, the quarter ending 30 Jun 2026, filed on 14 Aug 2026. Every figure below is the filing’s own: US-listed long equity, valued at the quarter end, with the change measured against the same manager’s previous filing.
Reported book is the quarter-end market value of the securities on the 13F, mostly US-listed long equity. It is not the manager’s assets under management: shorts, cash, leverage and most non-US or private holdings sit outside it.
Opened this quarter
A new position is the clearest thing a filing says. Somebody argued for it recently, and it is the easiest question to be ready for.
- Agilent Technologies Inc (A)$262m · 4.8%
- State Street SPDR S&P 500 ETF (SPY)puts$194m · 3.5%
- Eli Lilly & Co (LLY)$69m · 1.3%
- MKS Inc. (MKSI)$44m · 0.8%
- Stmicroelectronics N V (STM)NY Registry$42m · 0.8%
- Abbvie Inc (ABBV)$38m · 0.7%
- Astrazeneca PLC (AZN)$35m · 0.6%
- Elevance Health Inc Formerly (ELV)$26m · 0.5%
- Microchip Technology Inc. (MCHP)$24m · 0.4%
- Agilent Technologies Inc (A)calls$16m · 0.3%
- Bruker Corp (BRKR)$15m · 0.3%
- Novartis AG (NVS)Sponsored ADR$14m · 0.2%
- and 2 more, in the table below.
Sold out of this quarter
Exits are valued at what the position was worth in the previous filing, because by this one it is gone.
- Invesco QQQ Trust (QQQ)$189m held before
- DXC Technology Co (DXC)$112m held before
- Zoominfo Technologies Inc (GTM)$95m held before
- US Foods HLDG Corp (USFD)$35m held before
- Zillow Group Inc (Z)$33m held before
- Lithia MTRS Inc (LAD)$32m held before
- Lionsgate Studios Corp (LION)$27m held before
- Myriad Genetics Inc (MYGN)$24m held before
- Surgery Partners Inc (SGRY)$22m held before
- Akamai Technologies Inc (AKAM)$18m held before
- Intel Corp (INTC)$18m held before
- Biogen Inc (BIIB)$11m held before
Every reported position, Q2 2026
45 positions, sorted by weight
| Position | Weight ↓ | Value | Shares | Change on the quarter | Action |
|---|---|---|---|---|---|
| Global PMTS Inc (GPN) CUSIP 37940X102 | 12% | $646m | 8,906,709 | +$218m +2,546,317 shares | Added |
| CVS Health Corp (CVS) CUSIP 126650100 | 9.1% | $499m | 4,824,799 | -$90m -3,372,000 shares | Trimmed |
| Tenet Healthcare Corp (THC) CUSIP 88033G407 | 7.6% | $418m | 2,235,666 | +$131m +710,812 shares | Added |
| Thermo Fisher Scientific Inc (TMO) CUSIP 883556102 | 5.7% | $315m | 627,240 | +$191m +376,715 shares | Added |
| Amazon Com Inc (AMZN) CUSIP 023135106 | 5.5% | $303m | 1,271,687 | +$83m +212,417 shares | Added |
| iShares Russell 2000 ETF (IWM) puts · CUSIP 464287655 | 5.0% | $276m | 918,200 | +$183m +543,200 shares | Added |
| Agilent Technologies Inc (A) CUSIP 00846U101 | 4.8% | $262m | 1,969,541 | No earlier filing | New |
| Danaher Corp Del (DHR) CUSIP 235851102 | 4.0% | $218m | 1,145,979 | +$189m +989,704 shares | Added |
| Meta Platforms Inc (META) Class A · CUSIP 30303M102 | 3.7% | $201m | 356,841 | +$131m +234,179 shares | Added |
| State Street SPDR S&P 500 ETF (SPY) puts · CUSIP 78462F103 | 3.5% | $194m | 260,000 | No earlier filing | New |
| Advanced Micro Devices Inc (AMD) CUSIP 007903107 | 3.2% | $173m | 298,410 | +$41m -352,382 shares | Trimmed |
| Teva Pharmaceutical Inds LTD (TEVA) Sponsored ADS · CUSIP 881624209 | 3.1% | $172m | 5,081,091 | -$29m -1,579,129 shares | Trimmed |
| Viatris Inc (VTRS) CUSIP 92556V106 | 2.9% | $157m | 9,877,409 | +$34m +790,165 shares | Added |
| Uber Technologies Inc (UBER) CUSIP 90353T100 | 2.4% | $129m | 1,793,598 | +$25m +337,726 shares | Added |
| Centene Corp Del (CNC) CUSIP 15135B101 | 2.2% | $121m | 1,886,055 | +$16m -1,327,591 shares | Trimmed |
| Butterfly Network Inc (BFLY) Common Class A · CUSIP 124155102 | 2.2% | $121m | 14,335,055 | +$63m 0 shares | Held |
| The Cigna Group (CI) CUSIP 125523100 | 2.1% | $114m | 412,223 | -$19m -86,618 shares | Trimmed |
| Humana Inc (HUM) CUSIP 444859102 | 1.8% | $101m | 254,216 | +$43m -80,676 shares | Trimmed |
| Block Inc (XYZ) Class A · CUSIP 852234103 | 1.7% | $91m | 1,197,046 | +$8.9m -167,425 shares | Trimmed |
| Dicks Sporting Goods Inc (DKS) CUSIP 253393102 | 1.7% | $91m | 401,067 | +$32m +102,156 shares | Added |
| Genius Sports Limited (GENI) Shares Class A · CUSIP G3934V109 | 1.5% | $82m | 13,495,287 | +$44m +4,934,399 shares | Added |
| Onto Innovation Inc (ONTO) CUSIP 683344105 | 1.4% | $78m | 205,791 | +$16m -93,930 shares | Trimmed |
| Eli Lilly & Co (LLY) CUSIP 532457108 | 1.3% | $69m | 57,771 | No earlier filing | New |
| United Airls HLDGS Inc (UAL) CUSIP 910047109 | 1.2% | $67m | 494,736 | +$22m -2,124 shares | Trimmed |
| National Vision HLDGS Inc (EYE) CUSIP 63845R107 | 1.1% | $59m | 3,101,083 | +$18m +1,535,166 shares | Added |
| Cisco Sys Inc (CSCO) CUSIP 17275R102 | 0.9% | $49m | 413,332 | +$22m +73,513 shares | Added |
| Element Solutions Inc (ESI) CUSIP 28618M106 | 0.9% | $48m | 994,579 | -$8.1m -634,104 shares | Trimmed |
| Applied Matls Inc (AMAT) CUSIP 038222105 | 0.9% | $47m | 65,201 | -$20m -132,008 shares | Trimmed |
| MKS Inc. (MKSI) CUSIP 55306N104 | 0.8% | $44m | 98,532 | No earlier filing | New |
| Six Flags Entertainment Corp (FUN) CUSIP 83001C108 | 0.8% | $43m | 2,017,821 | +$3.5m -205,328 shares | Trimmed |
| Stmicroelectronics N V (STM) NY Registry · CUSIP 861012102 | 0.8% | $42m | 560,060 | No earlier filing | New |
| Abbvie Inc (ABBV) CUSIP 00287Y109 | 0.7% | $38m | 148,913 | No earlier filing | New |
| Astrazeneca PLC (AZN) CUSIP G0593M107 | 0.6% | $35m | 184,279 | No earlier filing | New |
| Bausch Plus Lomb Corp (BLCO) CUSIP 071705107 | 0.6% | $32m | 1,918,148 | +$1.4m +7,652 shares | Added |
| Baker Hughes Company (BKR) Class A · CUSIP 05722G100 | 0.5% | $27m | 493,519 | +$8.9m +189,844 shares | Added |
| Elevance Health Inc Formerly (ELV) CUSIP 036752103 | 0.5% | $26m | 66,599 | No earlier filing | New |
| Microchip Technology Inc. (MCHP) CUSIP 595017104 | 0.4% | $24m | 265,577 | No earlier filing | New |
| Agilent Technologies Inc (A) calls · CUSIP 00846U101 | 0.3% | $16m | 116,600 | No earlier filing | New |
| Bruker Corp (BRKR) CUSIP 116794108 | 0.3% | $15m | 252,169 | No earlier filing | New |
| Novartis AG (NVS) Sponsored ADR · CUSIP 66987V109 | 0.2% | $14m | 86,909 | No earlier filing | New |
| Digitalocean HLDGS Inc (DOCN) CUSIP 25402D102 | 0.2% | $13m | 84,812 | -$8.1m -165,188 shares | Trimmed |
| Primo Brands Corporation (PRMB) Class A Common Shares · CUSIP 741623102 | 0.2% | $9.9m | 404,971 | -$100k -126,080 shares | Trimmed |
| Boston Scientific Corp (BSX) CUSIP 101137107 | 0.1% | $4.8m | 113,096 | No earlier filing | New |
| Cardinal Health Inc (CAH) CUSIP 14149Y108 | 0.1% | $4.3m | 18,018 | No earlier filing | New |
| Bio-techne Corp (TECH) CUSIP 09073M104 | 0.1% | $4.1m | 58,324 | -$5.6m -127,988 shares | Trimmed |
Every filing on file
| Quarter | Period end | Filed | Book | Positions | Top 10 | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | 30 Jun 2026 | 14 Aug 2026 | $5.5bn | 45 | 61% | 13F-HR |
| Q1 2026 | 31 Mar 2026 | 15 May 2026 | $4.0bn | 44 | 61% | 13F-HR |
| Q4 2025 | 31 Dec 2025 | 17 Feb 2026 | $4.9bn | 57 | 60% | 13F-HR |
| Q3 2025 | 30 Sept 2025 | 14 Nov 2025 | $4.5bn | 54 | 65% | 13F-HR |
| Q2 2025 | 30 Jun 2025 | 14 Aug 2025 | $3.6bn | 43 | 68% | 13F-HR |
| Q1 2025 | 31 Mar 2025 | 15 May 2025 | $4.1bn | 45 | 67% | 13F-HR |
| Q4 2024 | 31 Dec 2024 | 14 Feb 2025 | $4.0bn | 36 | 65% | 13F-HR |
| Q3 2024 | 30 Sept 2024 | 14 Nov 2024 | $5.2bn | 46 | 64% | 13F-HR |
Taking this into the room
Pick one name from the top of the book and one from the new positions, and know both properly: what the company earns, what it is priced at, and what has to be true for the position to work. That is a conversation. Reciting the whole table is not, and the interviewer wrote it.
A position sold out of is worth as much preparation as one opened. Ask what changed rather than asserting the fund was wrong, and be ready for the answer that the thesis played out and the money went somewhere better.
What this filing leaves out
A 13F covers US-listed long equity at one moment in time. Shorts, bonds, cash, private positions and non-US listings never appear, and options are reported in a form that will mislead you if you read them as a position. A long/short manager showing $8bn here may run a book several times that size.
The lag matters too. Positions are as at the quarter end and the filing arrives up to forty-five days later, so what you are reading is at least six weeks old and possibly four months. Phrase it as what the filing showed, not what the fund holds today.
You have read the book. Now have a view on one name
Pick a position, work out what it is worth, and be ready to defend it. That is the difference between a candidate who read the filing and one who did something with it.
Company names, tickers and logos are the trademarks of their respective owners and appear here to identify the company whose public figures are being used. L3VLUP is not affiliated with, sponsored by or endorsed by any company shown, and nothing here is a statement by or about that company. More
This manager, next quarter, and the week between
One email a week on what moved in the market, with the 13F changes the quarter they are filed.
One email a week, free, and you can leave at any point.